Twitxy Saved

Katelynn Granger, PharmD, BCOP

@KG_PharmD

Myeloma/ Lymphoma Clinical Pharmacy Specialist @MUSChollings // @UNCPharmacy (she/her)
Charleston, SC Joined October 2019
389 Following 463 Followers 498 Posts

Latest posts 5

Katelynn Granger, PharmD, BCOP @KG_PharmD
The ❓ at ODAC matters! (shout out to recent @WolverHeme pod ep discussing the recent STARGLO and AQUILA- based decisions).. if the ❓ is about the “favorability of the proposed dosage”, makes sense that it’s going to be a no… but it still should be an option for patients IMO
CancerNetwork® Verified account @CancerNetwrk Jul 17, 2025
ODAC voted against the favorability of belantamab mafodotin in combination with dexamethasone and pomalidomide or bortezomib in multiple myeloma. #mmsm | @FDAOncology @US_FDA

cancernetwork.com/view/odac-vote…
View quoted post on X
Katelynn Granger, PharmD, BCOP @KG_PharmD
🌶️Hot off the press! 🌶️ Dexamethasone for CRS with teclistamab. You don't need toci for grade 1 CRS! great team work - @VictoriaNachar @CWagnerPharmD @kczmj @KLratermann @MikhailaPharmD @KG_PharmD @khouri_jack nature.com/articles/s4140…
View quoted post on X